(Total Views: 1063)
Posted On: 04/02/2019 8:05:40 AM
Post# of 73
$TROV News Article - Early Data from Phase 2 Trial Indicates Activity of Onvansertib in Prostate Cancer Patients Showing Initial Resistance to Anti-Androgen Therapy https://marketwirenews.com/news-releases/earl...31750.html
(0)
(0)
My Twitter: WhyteStocks
